These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31483364)

  • 1. Name Mix-Up: RifAMPin and Rifapentine.
    Shastay A
    Home Healthc Now; 2019; 37(5):295-296. PubMed ID: 31483364
    [No Abstract]   [Full Text] [Related]  

  • 2. Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.
    Dorman SE; Goldberg S; Stout JE; Muzanyi G; Johnson JL; Weiner M; Bozeman L; Heilig CM; Feng PJ; Moro R; Narita M; Nahid P; Ray S; Bates E; Haile B; Nuermberger EL; Vernon A; Schluger NW;
    J Infect Dis; 2012 Oct; 206(7):1030-40. PubMed ID: 22850121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifapentine for the treatment of tuberculosis: is it all it can be?
    Gordin FM
    Am J Respir Crit Care Med; 2004 Jun; 169(11):1176-7. PubMed ID: 15161608
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifapentine: its role in the treatment of tuberculosis.
    Temple ME; Nahata MC
    Ann Pharmacother; 1999 Nov; 33(11):1203-10. PubMed ID: 10573321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Adherence for 12 Weekly Doses of Isoniazid and Rifapentine for Pediatric Tuberculosis Infection.
    Cruz AT; Starke JR
    Pediatr Infect Dis J; 2016 Jul; 35(7):811-3. PubMed ID: 27088582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemolytic anemia secondary to rifampicin in patient diagnosed of pulmonary tuberculosis reinfection].
    Díaz-Pollán B; Peña-Pedrosa JA; Nuñez-Orantos MJ; Sotres-Fernández G
    Rev Esp Quimioter; 2013 Dec; 26(4):369-70. PubMed ID: 24399351
    [No Abstract]   [Full Text] [Related]  

  • 7. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Tuberculosis Trials Consortium.
    Vernon A; Burman W; Benator D; Khan A; Bozeman L
    Lancet; 1999 May; 353(9167):1843-7. PubMed ID: 10359410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombocytopenia--a rare but serious side effect of rifampicin.
    Shah NM; Venkatachalam S; Mehta Y; Balakrishnan C; Dubey SG; Mangat GK; Joshi VR
    J Assoc Physicians India; 1996 May; 44(5):359-60. PubMed ID: 9282598
    [No Abstract]   [Full Text] [Related]  

  • 9. Worsening of steroid dependent asthma : A possible role of rifampicin.
    Gupta D; Yadav S; Behera D; Jindal SK
    Indian J Chest Dis Allied Sci; 1995; 37(1):35-8. PubMed ID: 16892737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical worsening in tuberculosis during therapy in an HIV-infected patient.
    Mofredj A; Guérin JM; Leibinger F; Masmoudi R
    Infection; 1996; 24(5):390-1. PubMed ID: 8923052
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on rifampin, rifabutin, and rifapentine drug interactions.
    Baciewicz AM; Chrisman CR; Finch CK; Self TH
    Curr Med Res Opin; 2013 Jan; 29(1):1-12. PubMed ID: 23136913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Another step on the path to better TB therapies.
    Vernon A; Burman W; Horsburgh CR
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):1-2. PubMed ID: 11931394
    [No Abstract]   [Full Text] [Related]  

  • 13. Crescentic glomerulonephritis due to rifampin treatment in a patient with pulmonary atypical mycobacteriosis.
    Ogata H; Kubo M; Tamaki K; Hirakata H; Okuda S; Fujishima M
    Nephron; 1998; 78(3):319-22. PubMed ID: 9546693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy.
    Weiner M; Bock N; Peloquin CA; Burman WJ; Khan A; Vernon A; Zhao Z; Weis S; Sterling TR; Hayden K; Goldberg S;
    Am J Respir Crit Care Med; 2004 Jun; 169(11):1191-7. PubMed ID: 14962821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosis.
    Rosenthal IM; Williams K; Tyagi S; Vernon AA; Peloquin CA; Bishai WR; Grosset JH; Nuermberger EL
    Am J Respir Crit Care Med; 2005 Dec; 172(11):1457-62. PubMed ID: 16141439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
    Stout JE
    Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifapentine.
    Tuberculosis (Edinb); 2008 Mar; 88(2):155-8. PubMed ID: 18486059
    [No Abstract]   [Full Text] [Related]  

  • 18. Carry on doctor.
    Nair S; Carroll WD
    Arch Dis Child; 2009 Sep; 94(9):734-5. PubMed ID: 19700428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?
    Alfarisi O; Alghamdi WA; Al-Shaer MH; Dooley KE; Peloquin CA
    Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1027-1036. PubMed ID: 28803492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Four cases of similar Hexheimer's reaction during the initial chemotherapy for tuberculosis bacillus].
    Lu H; Wu H; Liang G
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Dec; 18(6):348-50, 382-3. PubMed ID: 8762493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.